CYCN cyclerion.com: Kapitalisasi pasar

This daily price chart for Cyclerion Therapeutics (CYCN), where the market capitalization stands at 0.01, demonstrates the activity of an issuer developing orphan drugs that require strict temperature control during transport. Current structural shifts within Cyclerion Therapeutics (CYCN) are already priced in, while growth drivers for sGC stimulators have yet to materialize. The business relies on the modulation of brain pathways for neuronal rehabilitation in specific CNS pathologies.

CYCN Cyclerion Therapeutics Inc.: Kapitalisasi pasar ing interval 04.07.2022 - 09.09.2026

CYCN (cyclerion.com): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Cyclerion Therapeutics (CYCN):

Kutipan saham Cyclerion Therapeutics, Inc.|CYCN - Rata-rata rega prakiraan|Kapitalisasi pasar Cyclerion Therapeutics

Analisis fundamental perusahaan:CYCN (Cyclerion)

Sampel barang Cyclerion Therapeutics Inc.

The scale of Cyclerion Therapeutics (CYCN) operations in neuropharmacology determines its market value. This metric is calculated as the product of the current share price and the total number of outstanding securities. It reflects the aggregate investor valuation of the potential for neuron recovery in rare disorders. This price action captures the market's reaction to the company's scientific achievements. Analyzing the issuer's market capitalization allows for an objective assessment of the business's real value.

Pesaing wigati

Biogen - Biji pasar|Neurocrine (NBIX) - Nilai pasar|Regencell - Kapitalisasi pasar|Axsome Corp (AXSM) - Biji pasar|ACADIA Pharmaceuticals (ACAD) - Nilai pasar|Kapitalisasi pasar XENE|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|CBLL (CeriBell, Inc.) - Kapitalisasi pasar|Biji pasar Prothena Corp (PRTA)|Biji pasar ALEC (Alector, Inc.)|ANNX - Nilai pasar|Kapitalisasi pasar OMER (Omeros)|NGNE - Biji pasar|ACIU - Nilai pasar|VYGR: Nilai pasar|NMRA: Kapitalisasi pasar|Nilai pasar Scilex Holding (SCLX)|Nilai pasar Tevogen Bio Holdings, Inc.|ACOG: Nilai pasar|Kapitalisasi pasar CGTX|Kapitalisasi pasar inhibikase.com|Nilai pasar Cassava Sciences SAVA|Assertio Holdings (ASRT) - Nilai pasar|COYA - Nilai pasar|VTGN (Vistagen Therapeutics) - Kapitalisasi pasar|OVID (ovidrx.com) - Biji pasar|acumenpharm.com - Nilai pasar|Biji pasar CRVO|ATHE (Alterity Therapeutics Ltd) - Nilai pasar|Kapitalisasi pasar CLNN|PEPG (pepgen.com) - Nilai pasar|Kapitalisasi pasar JUNS (Jupiter Neurosciences)|relmada.com (RLMD) - Nilai pasar|ANVS - Nilai pasar|Nilai pasar GRCE (Grace Therapeutics, Inc.)|AIFF: Kapitalisasi pasar|Klotho Neurosciences (KLTO) - Kapitalisasi pasar|Nilai pasar NeuroSense Therapeutics Ltd|revivapharma.com - Biji pasar|Kapitalisasi pasar MTVA|NRXS - Nilai pasar|Helius Medical Technologies - Biji pasar|Kapitalisasi pasar Passage Bio Inc. PASG|NEUP: Biji pasar|minervaneurosciences.com - Nilai pasar|ATHA: Kapitalisasi pasar|ADXN - Kapitalisasi pasar|ALZN (Alzamend Neuro Inc.) - Kapitalisasi pasar|Biji pasar Protagenic (PTIX)|Nilai pasar Pasithea Therapeutics (KTTA)|Kapitalisasi pasar cortigent.com|Kapitalisasi pasar ATXI (Avenue Therapeutics, Inc.)|BCLI - Biji pasar|CARA: Biji pasar|Nilai pasar Chromocell|ELYM: Kapitalisasi pasar|Biji pasar Intra-Cellular Therapies, Inc.|Nilai pasar Longboard Pharmaceuticals, Inc.|Kapitalisasi pasar MRNS (Marinus Pharmaceuticals Inc)|Nilai pasar NKGen (NKGN)|NeuroBo Pharma - Kapitalisasi pasar|Kapitalisasi pasar SAGE (Sage Therapeutics, Inc.)|synaptogen.com (SNPX) - Nilai pasar|TRVN: Biji pasar|VIGL - Kapitalisasi pasar|Anew Medical, Inc. (WENA) - Nilai pasar|Cerevel Corp - Nilai pasar